The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection
Minerva Med
.
2021 Aug;112(4):514-516.
doi: 10.23736/S0026-4806.21.07487-5.
Epub 2021 Mar 12.
Authors
Francesco DI Pierro
1
2
,
Maria Colombo
3
Affiliations
1
Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.
2
Digestive Endoscopic Unit and Gastroenterology, Fondazione Poliambulanza, Brescia, Italy - f.dipierro@vellejaresearch.com.
3
ATS Milano, Milan, Italy.
PMID:
33709676
DOI:
10.23736/S0026-4806.21.07487-5
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / prevention & control*
Child
Humans
Probiotics / therapeutic use*
Streptococcus salivarius*